| Home | Log In | Register | Our Services | My Account | Contact | Help |
Midatech Pharma (MTPH)
dreamcatcher
- 05 Jan 2015 17:23
Midatech is a nanomedicine company focused on the development and commercialisation of multiple, high-value, targeted therapies for major diseases with unmet medical need.
Midatech is advancing a pipeline of novel clinical and pre-clinical product candidates based on its proprietary drug conjugate and sustained release delivery platforms with a clear focus on the key therapeutic areas of diabetes, cancer and ophthalmology. Midatech’s strategy is to develop its products in-house in rare cancers and with partners in other indications, and to accelerate growth of its business through strategic acquisition of complementary products and technologies.
Midatech’s shares are traded on the Alternative Investment Market (AIM) of the London Stock Exchange under the ticker symbol MTPH (ISIN number GB00BRTL9B63).
Admission and First Day of Dealings on 8 December 2014
Major shareholders
http://www.midatechpharma.com/investors/share-information
http://www.midatechpharma.com/
Bullshare
- 29 Jun 2017 11:37
- 22 of 23
Come and celebrate 6 years of investor evenings with Shares on July 11 and receive a Shares goody bag worth over £150!.
We can’t believe that 6 years have passed since we started our investor evenings, in that time many 1000’s of private investors, fund managers, brokers and analysts have come along and heard from 100’s of listed companies present their investment opportunity.
To celebrate our next investor evening on 11 July in London, we will give all attendees a free goody bag containing:
1) a one year subscription to Shares magazine digital. Each week you will receive the latest Shares digital weekly magazine where our team of experts will give you a multitude of investment ideas. You will also gain access to the Shares investor toolkit with live news, LIVE share prices, portfolio and research tools (value £120)
2) a bottle of champagne (value £20)
3) The DIY Investor book written by Andy Bell, CEO of AJ Bell (RRP £17.99)
On the evening hear from:
MetalNRG (NEX.MNRG) - MetalNRG is an NEX Exchange quoted natural resource investing company seeking investments in precious and strategic metals. Metal NRG is reviewing opportunities in various commodities and jurisdictions and anticipates updating the market shortly with regard to its initial target investments. It recently announced its first investing step with the creation of the Palomino Cobalt Project in Western Australia. MetalNRG’s CEO, the well-known resources entrepreneur Paul Johnson (ex-CEO of Metal Tiger), will provide an update on the company’s investment strategy.
Midatech Pharma (MTPH) - Midatech has a balanced portfolio of fast-growth marketed oncology products and development programmes for its own products, using its proprietary platform technologies to target diseases with unmet medical need. Midatech offers the potential for rapid revenue growth through its differentiated product portfolio and exciting development pipeline, supported by strong IP and, an ambitious and highly experienced leadership team.
Sphere Medical (SPHR) - Sphere Medical’s vision is to become a leading solution provider to the critical care market offering innovative, frequent on demand, point of care diagnostic and monitoring products to enable closer control of therapeutic response, improve patient outcomes and reduce the overall cost of care. The Company’s strategy is focused on the Proxima platform for measuring blood gases, electrolytes and metabolites. The latest generation of the product, Proxima 4, was launched in December 2016 and is being marketed directly to the critical care market in the UK, Germany, The Netherlands and Belgium, and by distributors in Italy and Spain.
Xpediator - Xpediator Plc is expected to IPO on the London Stock Exchange’s AIM market in July 2017. It is a well-established international provider of freight management services operating across the UK and Europe with a particular focus on, and expertise in, the CEE markets. The Group currently employs over 600 people with its operational headquarters in Braintree, England, and country offices in Bulgaria, Lithuania, Estonia, Macedonia, Montenegro, Moldova, Romania and Serbia operating from 22 sites in total.
Places at this event are very limited, so register now for your free ticket.
The evening is a perfect opportunity for existing shareholders or potential investors to hear from those that matter, the directors running the companies and fund managers managing their fund. Who better to explain the future potential and strategy.
Tuesday 11 July 2017
Venue:Novotel Tower Bridge, London EC3N 2NR, 10 Pepys Street, London, EC3N 2NR
Event Timings:| 18.00 | Registration and coffee | |
| 18.30 | Presentations • Paul Johnson, CEO - Metal NRG (MNRG) • Dr Jim Phillips, CEO - Midatech Pharma (MTPH) • Dr Wolfgang Rencken, CEO - Sphere Medical (SPHR) • Stephen Blyth, CEO - Xpediator + More to be announced | |
| 20.30 | Drinks reception and canapés | |
| 21.30 | Close |
 | Metal NRG is an NEX Exchange quoted natural resource investing company seeking investments in precious and strategic metals. Metal NRG is reviewing opportunities in various commodities and jurisdictions and anticipates updating the market shortly with regard to its initial target investments.
|
 | Midatech is a nanomedicine company focused on the development and commercialisation of multiple, high-value, targeted therapies for major diseases with unmet medical need. It is advancing a pipeline of novel clinical and pre-clinical product candidates based on its proprietary drug conjugate and sustained release delivery platforms with a clear focus on the key therapeutic areas of diabetes, cancer and neuroscience/ophthalmology. Midatech’s strategy is to develop its products in-house in rare cancers and with partners in other indications, and to accelerate growth of its business through strategic acquisition of complementary products and technologies. |
 | Sphere Medical is a dynamic and growing company specialising in the development of innovative medical monitoring and diagnostic equipment. Their products are used in a wide range of medical applications, enabling faster clinical decision-making and improved patient outcomes, whilst providing efficiencies that result in reduced healthcare costs. |
 | Xpediator is the holding company for the Group, a well-established international provider of freight management services operating across the UK and Europe with a particular focus on, and expertise in, the CEE markets. he Group currently employs over 600 people with its operational headquarters in Braintree, England, and country offices in Bulgaria, Lithuania, Estonia, Macedonia, Montenegro, Moldova, Romania and Serbia operating from 22 sites in total. The Group has three main business areas which are managed autonomously on a day-to-day basis but directed centrally to cross-sell services to the Group’s customer base: - Freight forwarding, trading under the Delamode brand. - Logistics and warehousing, trading under the Delamode brand and EMT; and pallet distribution services, trading under the Pall-Ex brand. - Transport services, trading under the Affinity brand.
|
Bullshare
- 17 Aug 2017 12:22
- 23 of 23
Shares and AJ Bell Media are returning to Edinburgh and will be hosting an Investor Evening where senior board directors from fast growing listed PLCs will make a presentation about their company and update existing & potential investors on their business plans.
During the event and afterwards over drinks, investors will have the chance to discover new investment opportunities and get to know the companies better by talking one on one with the company directors.
The event will take place at the Radisson Blu Hotel, 80 High Street, The Royal Mile, Edinburgh EH11TH.
Corero Network Security (CNS) - Corero Network Security is the leader in real-time, high-performance DDoS defense solutions. Service providers, hosting providers and online enterprises rely on Corero's award winning technology to eliminate the DDoS threat to their environment through automatic attack detection and mitigation, coupled with complete network visibility, analytics and reporting. This next-generation technology provides a First Line of Defense® against DDoS attacks in the most complex environments while enabling a more cost effective economic model than previously available.
Midatech Pharma (MTPH) - Midatech is a nanomedicine company focused on the development and commercialisation of multiple, high-value, targeted therapies for major diseases with unmet medical need. It is advancing a pipeline of novel clinical and pre-clinical product candidates based on its proprietary drug conjugate and sustained release delivery platforms with a clear focus on the key therapeutic areas of diabetes, cancer and neuroscience/ophthalmology. Midatech’s strategy is to develop its products in-house in rare cancers and with partners in other indications, and to accelerate growth of its business through strategic acquisition of complementary products and technologies.
NEX Exchange - NEX Exchange is used by entrepreneurs and individuals to manage their financial challenges. They give companies of all sizes, from micro to mid-caps, access to a public quote or a fully regulated listing. For investors, they offer simple access to a diverse range of dynamic, small and medium sized companies and to a variety of equity or debt products. For ambitious companies and investors, NEX Exchange is a platform for growth.
Prairie Mining (PDZ) - Prairie Mining is a multi-project coal development company focused on the development and operation of the Jan Karski Mine in the Lublin Coal Basin and the Debiensko Hard Coking Coal Project in Upper Silesia. Located within the heartland of industrial Europe with large scale coal resources and excellent access to infrastructure, Prairie’s vision is to become Europe's lowest cost supplier of premium coal to supply European industry.
The evening exposes investors to companies across various sectors. Perfect for existing investors as well as those looking for new investment opportunities.
Thursday 21 September 2017
Venue:Radisson Blu Hotel Edinburgh, 80 High Street, The Royal Mile, Edinburgh, EH11TH
Event Timings:| 18.00 | Registration and coffee | |
| 18.30 | Presentations • Dr Jim Phillips, CEO - Midatech Pharma (MTPH) • Max Raynor, Sales - NEX Exchange | |
| 20.30 | Drinks reception and canapés | |
| 21.30 | Close |
 | DDoS attacks continue to rise in size, frequency, and complexity, impacting the security and availability of the Internet. Service providers and the Internet connected business require automatic protection against this evolving threat landscape. Corero Network Security is dedicated to improving the security and availability of the Internet through the deployment of innovative DDoS & Network Security Solutions. The Corero SmartWall® Threat Defense System (TDS) family of products can be deployed in various topologies, (in-line or scrubbing). the SmartWall Threat Defense System (TDS) family of solutions utilizes modern DDoS mitigation architecture to automatically, and surgically remove DDoS attack traffic, while allowing good user traffic to flow uninterrupted. |
| Midatech is a nanomedicine company focused on the development and commercialisation of multiple, high-value, targeted therapies for major diseases with unmet medical need. It is advancing a pipeline of novel clinical and pre-clinical product candidates based on its proprietary drug conjugate and sustained release delivery platforms with a clear focus on the key therapeutic areas of diabetes, cancer and neuroscience/ophthalmology. Midatech’s strategy is to develop its products in-house in rare cancers and with partners in other indications, and to accelerate growth of its business through strategic acquisition of complementary products and technologies. |
 | Prairie Mining Limited (ASX/LSE/WSE: PDZ) is a multi-project coal development company focused on the development and operation of the Jan Karski Mine in the Lublin Coal Basin and the Debiensko Hard Coking Coal Project in Upper Silesia. Located within the heartland of industrial Europe with large scale coal resources and excellent access to infrastructure, Prairie’s vision is to become Europe's lowest cost supplier of premium coal to supply European industry. |
- Page:
- 1
- 2
| About MoneyAM | Ts and Cs | Privacy Policy | Investment Warning | Content Standards | Corporate Solutions | Advertise With Us | Site Map | © 2025 MoneyAM |
Follow us on Twitter